{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:56:55Z","timestamp":1781787415060,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejphar.2023.175716","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T10:12:30Z","timestamp":1681380750000},"page":"175716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Multi-pathway neuroprotective effects of a novel salidroside derivative SHPL-49 against acute cerebral ischemic injury"],"prefix":"10.1016","volume":"949","author":[{"given":"Pei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junchao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsen","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiange","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2023.175716_bib1","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1161\/STROKEAHA.111.618850","article-title":"Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies","volume":"42","author":"Albers","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.175716_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00709-019-01439-2","article-title":"Ischemic stroke and mitochondria: mechanisms and targets","volume":"257","author":"Andrabi","year":"2020","journal-title":"Protoplasma"},{"key":"10.1016\/j.ejphar.2023.175716_bib3","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0140-6736(17)33151-3","article-title":"A randomised controlled multimodal intervention trial in patients with ischaemic stroke in Shandong, China: design and rationale","volume":"390","author":"Bai","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2023.175716_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/aps.2018.5","article-title":"Discovery and development of NA-1 for the treatment of acute ischemic stroke","volume":"39","author":"Ballarin","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2023.175716_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/01.STR.17.3.472","article-title":"Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination","volume":"17","author":"Bederson","year":"1986","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.175716_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12883-017-1007-y","article-title":"Reperfusion therapy in acute ischemic stroke: dawn of a new era?","volume":"18","author":"Bhaskar","year":"2018","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ejphar.2023.175716_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nm0102-5a","article-title":"Future of neuroprotective drugs in doubt","volume":"8","author":"Birmingham","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2023.175716_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2040-7378-1-8","article-title":"Rodent models of focal cerebral ischemia: procedural pitfalls and translational problems","volume":"1","author":"Braeuninger","year":"2009","journal-title":"Exp. Transl. Stroke Med."},{"key":"10.1016\/j.ejphar.2023.175716_bib9","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1474-4422(16)00114-9","article-title":"Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation","volume":"15","author":"Chamorro","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2023.175716_bib10","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ncl.2013.03.009","article-title":"New strategies for endovascular recanalization of acute ischemic stroke","volume":"31","author":"Cohen","year":"2013","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.ejphar.2023.175716_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.annepidem.2011.03.010","article-title":"Worldwide clinical interventional studies on leading causes of death: a descriptive analysis","volume":"21","author":"Dal-R\u00e9","year":"2011","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.ejphar.2023.175716_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2023.175716_bib13","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000069318","article-title":"Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters","volume":"15","year":"2003","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.ejphar.2023.175716_bib14","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/01.STR.0000173403.60553.27","article-title":"Enhancing the development and approval of acute stroke therapies: stroke Therapy Academic Industry roundtable","volume":"36","author":"Fisher","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.175716_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/neu.1994.11.345","article-title":"Behavioral deficits following experimental subarachnoid hemorrhage in the rat","volume":"11","author":"German\u00f2","year":"1994","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2023.175716_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuropharm.2007.12.007","article-title":"Neuroprotection for ischemic stroke: past, present and future","volume":"55","author":"Ginsberg","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2023.175716_bib17","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s11064-020-03060-9","article-title":"\u03b2-Asarone exerts antioxidative effects on H2O2-stimulated PC12 cells by activating Nrf2\/HO-1 pathway","volume":"45","author":"Hei","year":"2020","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2023.175716_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s10157-008-0108-8","article-title":"Determinants for the prognosis of acute renal disorders that developed during or after treatment with edaravone","volume":"13","author":"Hishida","year":"2009","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.ejphar.2023.175716_bib19","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.apsb.2020.11.019","article-title":"Recent advances in nanomedicines for the treatment of ischemic stroke","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejphar.2023.175716_bib20","first-page":"7287","article-title":"Neuroprotective effects of salidroside administration in a mouse model of Alzheimer's disease","volume":"17","author":"Li","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejphar.2023.175716_bib21","first-page":"1","article-title":"Hydroxy- \u03b1 -sanshool possesses protective potentials on H 2 O 2 -stimulated PC12 cells by suppression of oxidative stress-induced apoptosis through regulation of PI3K\/akt signal pathway","author":"Li","year":"2020","journal-title":"Oxidative Medicine and Cellular Longevity 2020"},{"key":"10.1016\/j.ejphar.2023.175716_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172944","article-title":"Neuroprotective effect of salvianolate on cerebral ischaemia-reperfusion injury in rats by inhibiting the Caspase-3 signal pathway","volume":"872","author":"Luan","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175716_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3736\/jcim20090308","article-title":"[Protective effects of salidroside on oxidative damage in fatigue mice]","volume":"7","author":"Ma","year":"2009","journal-title":"Zhong Xi Yi Jie He Xue Bao"},{"key":"10.1016\/j.ejphar.2023.175716_bib24","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s12264-019-00371-y","article-title":"MicroRNA-365 knockdown prevents ischemic neuronal injury by activating oxidation resistance 1-mediated antioxidant signals","volume":"35","author":"Mo","year":"2019","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2023.175716_bib25","first-page":"1","article-title":"The effects of folic acid administration on cardiac oxidative stress and cardiovascular biomarkers in diabetic rats","author":"Mutavdzin","year":"2019","journal-title":"Oxidative Medicine and Cellular Longevity 2019"},{"key":"10.1016\/j.ejphar.2023.175716_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109552","article-title":"Anti-inflammatory effects of Rhodiola rosea L.: a review","volume":"121","author":"Pu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2023.175716_bib27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1080\/21691401.2019.1584566","article-title":"Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK\/ERK signal pathway","volume":"47","author":"Ren","year":"2019","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.ejphar.2023.175716_bib28","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-011-9290-7","article-title":"Neuroprotective effects of Salidroside and its analogue tyrosol galactoside against focal cerebral ischemia in vivo and H2O2-induced neurotoxicity in vitro","volume":"21","author":"Shi","year":"2012","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2023.175716_bib29","doi-asserted-by":"crossref","DOI":"10.18091\/ijsts.4122","article-title":"Molecular pathways of ischemic stroke and advanced therapeutic strategies","volume":"4","author":"Singh","year":"2018","journal-title":"IJSTS"},{"key":"10.1016\/j.ejphar.2023.175716_bib30","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1161\/01.STR.30.12.2752","article-title":"Recommendations for standards regarding preclinical neuroprotective and restorative drug development","volume":"30","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.175716_bib31","doi-asserted-by":"crossref","first-page":"7373","DOI":"10.3390\/ijms21197373","article-title":"Lipid emulsion improves functional recovery in an animal model of stroke","volume":"21","author":"Tanioka","year":"2020","journal-title":"IJMS"},{"key":"10.1016\/j.ejphar.2023.175716_bib32","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/jcmm.13368","article-title":"Salidroside attenuates neuroinflammation and improves functional recovery after spinal cord injury through microglia polarization regulation","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2023.175716_bib33","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/STROKEAHA.110.604249","article-title":"Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National stroke registry (CNSR)","volume":"42","author":"Wang","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2023.175716_bib34","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1007\/s12035-020-02021-1","article-title":"A review of exercise-induced Neuroplasticity in ischemic stroke: pathology and mechanisms","volume":"57","author":"Xing","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2023.175716_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.638209","article-title":"Neuroprotective and angiogenesis effects of Levetiracetam following ischemic stroke in rats","volume":"12","author":"Yao","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175716_bib36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2174\/15701611113119990016","article-title":"Angiogenesis-regulating microRNAs and ischemic stroke","volume":"13","author":"Yin","year":"2015","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175716_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.atherosclerosis.2004.10.037","article-title":"Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase","volume":"179","author":"Yoshida","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2023.175716_bib38","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejphar.2009.01.046","article-title":"Salidroside protects cardiomyocyte against hypoxia-induced death: a HIF-1alpha-activated and VEGF-mediated pathway","volume":"607","author":"Zhang","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175716_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112212","article-title":"Improvement in mitochondrial function underlies the effects of ANNAO tablets on attenuating cerebral ischemia-reperfusion injuries","volume":"246","author":"Zhang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejphar.2023.175716_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pharmthera.2018.05.012","article-title":"Advances in stroke pharmacology","volume":"191","author":"Zhou","year":"2018","journal-title":"Pharmacol. Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923002273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:42:29Z","timestamp":1736347349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923002273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":40,"alternative-id":["S0014299923002273"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175716","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-pathway neuroprotective effects of a novel salidroside derivative SHPL-49 against acute cerebral ischemic injury","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175716"}}